These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 27930821
1. Assessment of asymmetrical dimethylarginine metabolism in patients with critical illness. Ghashut RA, Blackwell S, Ryan S, Willox L, McMillan DC, Kinsella J, Talwar D. Eur J Clin Invest; 2017 Apr; 47(4):279-288. PubMed ID: 27930821 [Abstract] [Full Text] [Related]
2. Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival. Winkler MS, Nierhaus A, Rösler G, Lezius S, Harlandt O, Schwedhelm E, Böger RH, Kluge S. Crit Care; 2018 Sep 19; 22(1):216. PubMed ID: 30231905 [Abstract] [Full Text] [Related]
3. The effect of rosiglitazone on asymmetric dimethylarginine (ADMA) in critically ill patients. Richir MC, Ellger B, Teerlink T, Siroen MP, Visser M, Spreeuwenberg M, Girbes AR, van der Hoven B, van den Berghe G, Wilhelm AJ, de Vries TP, van Leeuwen PA. Pharmacol Res; 2009 Dec 19; 60(6):519-24. PubMed ID: 19559792 [Abstract] [Full Text] [Related]
4. ADMA and homoarginine independently predict mortality in critically ill patients. Lee TF, Bersten AD, Heilbronn LK, Zinellu A, Carru C, Sotgia S, Mangoni AA, Burt MG. Nitric Oxide; 2022 May 01; 122-123():47-53. PubMed ID: 35367633 [Abstract] [Full Text] [Related]
5. Association of homoarginine and methylarginines with liver dysfunction and mortality in chronic liver disease. Pilz S, Putz-Bankuti C, Meinitzer A, März W, Kienreich K, Stojakovic T, Pieber TR, Stauber RE. Amino Acids; 2015 Sep 01; 47(9):1817-26. PubMed ID: 25952253 [Abstract] [Full Text] [Related]
6. Changes in nitric oxide inhibitors and mortality in critically ill patients: a cohort study. Mortensen KM, Itenov TS, Stensballe J, Hillig T, Jensen CAJ, Schønemann-Lund M, Bestle MH. Ann Intensive Care; 2024 Aug 27; 14(1):133. PubMed ID: 39190083 [Abstract] [Full Text] [Related]
7. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency. Betz B, Möller-Ehrlich K, Kress T, Kniepert J, Schwedhelm E, Böger RH, Wanner C, Sauvant C, Schneider R. Transl Res; 2013 Aug 27; 162(2):67-76. PubMed ID: 23707198 [Abstract] [Full Text] [Related]
8. Serum reference intervals of homoarginine, ADMA, and SDMA in the study of health in Pomerania. Atzler D, Schwedhelm E, Nauck M, Ittermann T, Böger RH, Friedrich N. Clin Chem Lab Med; 2014 Dec 27; 52(12):1835-42. PubMed ID: 24945429 [Abstract] [Full Text] [Related]
9. Glycemic control modulates arginine and asymmetrical-dimethylarginine levels during critical illness by preserving dimethylarginine-dimethylaminohydrolase activity. Ellger B, Richir MC, van Leeuwen PA, Debaveye Y, Langouche L, Vanhorebeek I, Teerlink T, Van den Berghe G. Endocrinology; 2008 Jun 27; 149(6):3148-57. PubMed ID: 18292189 [Abstract] [Full Text] [Related]
10. Homoarginine/ADMA ratio and homoarginine/SDMA ratio as independent predictors of cardiovascular mortality and cardiovascular events in lower extremity arterial disease. Jud P, Hafner F, Verheyen N, Meinitzer A, Gary T, Brodmann M, Seinost G, Hackl G. Sci Rep; 2018 Sep 21; 8(1):14197. PubMed ID: 30242192 [Abstract] [Full Text] [Related]
11. Plasma concentrations of arginine and asymmetric dimethylarginine do not reflect their intracellular concentrations in peripheral blood mononuclear cells. Davids M, Teerlink T. Metabolism; 2013 Oct 21; 62(10):1455-61. PubMed ID: 23890667 [Abstract] [Full Text] [Related]
12. Time course of endogenous nitric oxide inhibitors in severe sepsis in humans. Iapichino G, Umbrello M, Albicini M, Spanu P, Bellani G, Polli F, Pavlovic R, Cugno M, Fermo I, Paroni R. Minerva Anestesiol; 2010 May 21; 76(5):325-33. PubMed ID: 20395894 [Abstract] [Full Text] [Related]
13. Imbalance of arginine and asymmetric dimethylarginine is associated with markers of circulatory failure, organ failure and mortality in shock patients. Visser M, Vermeulen MA, Richir MC, Teerlink T, Houdijk AP, Kostense PJ, Wisselink W, de Mol BA, van Leeuwen PA, Oudemans-van Straaten HM. Br J Nutr; 2012 May 21; 107(10):1458-65. PubMed ID: 22129964 [Abstract] [Full Text] [Related]
14. HPLC analysis of asymmetric dimethylarginine, symmetric dimethylarginine, homoarginine and arginine in small plasma volumes using a Gemini-NX column at high pH. Jones CE, Darcy CJ, Woodberry T, Anstey NM, McNeil YR. J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jan 01; 878(1):8-12. PubMed ID: 19945921 [Abstract] [Full Text] [Related]
15. Arginine, dimethylated arginine and homoarginine in relation to cardiovascular risk in patients with moderate chronic kidney disease. Hov GG, Aasarød KI, Sagen E, Åsberg A. Clin Biochem; 2015 Jul 01; 48(10-11):646-51. PubMed ID: 25828044 [Abstract] [Full Text] [Related]
16. Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology? Busch M, Fleck C, Wolf G, Stein G. Amino Acids; 2006 May 01; 30(3):225-32. PubMed ID: 16680555 [Abstract] [Full Text] [Related]
17. Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality. Nijveldt RJ, Teerlink T, Van Der Hoven B, Siroen MP, Kuik DJ, Rauwerda JA, van Leeuwen PA. Clin Nutr; 2003 Feb 01; 22(1):23-30. PubMed ID: 12553946 [Abstract] [Full Text] [Related]
18. Health-associated reference values for arginine, asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) measured with high-performance liquid chromatography. Hov GG, Sagen E, Bigonah A, Asberg A. Scand J Clin Lab Invest; 2007 Feb 01; 67(8):868-76. PubMed ID: 17852822 [Abstract] [Full Text] [Related]
19. Elevated asymmetric dimethylarginine levels predict short- and long-term mortality risk in critically ill patients. Koch A, Weiskirchen R, Kunze J, Dückers H, Bruensing J, Buendgens L, Matthes M, Luedde T, Trautwein C, Tacke F. J Crit Care; 2013 Dec 01; 28(6):947-53. PubMed ID: 23953490 [Abstract] [Full Text] [Related]
20. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and L-arginine in patients with arteriogenic and non-arteriogenic erectile dysfunction. Paroni R, Barassi A, Ciociola F, Dozio E, Finati E, Fermo I, Ghilardi F, Colpi GM, Corsi MM, Melzi d'Eril GV. Int J Androl; 2012 Oct 01; 35(5):660-7. PubMed ID: 22519580 [Abstract] [Full Text] [Related] Page: [Next] [New Search]